Addison-Davis Diagnostics Receives Second Purchase Order From Miami-Dade County for "Drug-Stop"
WESTLAKE VILLAGE, CA, Oct 03, 2005 (MARKET WIRE via COMTEX) -- Addison-Davis Diagnostics, Inc. (ADDI) is pleased to announce that they have already received their second purchase order from Miami-Dade County, FL. This time the purchase order is for the Internal Affairs Department. In August, Addison-Davis was awarded a bid to exclusively supply "Drug Stop," the Addison-Davis on site drug screening test, to the Turner Guilford Knight Correctional Center.
"Drug Stop" has already received 510K and Over-The-Counter Clearance from the FDA. "Drug Stop" is a self-regulating urine specimen test using the latest on-site drug screening technology. The process used by the "Drug Stop" product is one of the easiest to use on-site drug screening tests. Addison-Davis is targeting the $2.2 Billion substance abuse market with "Drug Stop."
Addison-Davis Diagnostics, Inc. is responding to industry demands by supplying quick response diagnostic tests that are user friendly, produce fast simple results and are less costly, less problematic and less time consuming. Addison-Davis is currently focused on bringing fast and reliable "Point-of-care" Diagnostic Testing through the use of its patented technology to Healthcare Professionals, Hospitals, certain branches of the Government and the Workplace environment for drugs-of-abuse and medical conditions and diseases.
Price Support Pivot Point Resistance
0.0180 0.0147 0.0197 0.0247